{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "regularMarketChangePercent": -2.8529575, "regularMarketPrice": 0.7287, "exchange": "LSE", "shortName": "NEKTAR THERAPEUTICS NEKTAR THER", "longName": "Nektar Therapeutics", "messageBoardId": "finmb_29929", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "marketState": "POSTPOST", "esgPopulated": false, "sharesOutstanding": 173084992, "bookValue": 1.944, "fiftyDayAverage": 0.95139, "fiftyDayAverageChange": -0.22269005, "fiftyDayAverageChangePercent": -0.2340681, "twoHundredDayAverage": 2.8664706, "twoHundredDayAverageChange": -2.1377707, "twoHundredDayAverageChangePercent": -0.74578494, "marketCap": 1249385, "priceToBook": 0.37484568, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1531897200000, "priceHint": 4, "regularMarketChange": -0.021400034, "regularMarketTime": 1683905536, "regularMarketDayHigh": 0.7287, "regularMarketDayRange": "0.7287 - 0.7287", "regularMarketDayLow": 0.7287, "regularMarketVolume": 17, "regularMarketPreviousClose": 0.7501, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "LSE", "financialCurrency": "USD", "regularMarketOpen": 0.7287, "averageDailyVolume3Month": 4642, "averageDailyVolume10Day": 1700, "fiftyTwoWeekLowChange": 0.10569996, "fiftyTwoWeekLowChangePercent": 0.16966285, "fiftyTwoWeekRange": "0.623 - 5.11", "fiftyTwoWeekHighChange": -4.3813, "fiftyTwoWeekHighChangePercent": -0.85739726, "fiftyTwoWeekLow": 0.623, "fiftyTwoWeekHigh": 5.11, "earningsTimestamp": 1683666000, "earningsTimestampStart": 1691006400, "earningsTimestampEnd": 1691438400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.664, "symbol": "0UNL.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "455 Mission Bay Boulevard South", "city": "San Francisco", "state": "CA", "zip": "94158", "country": "United States", "phone": "415 482 5300", "fax": "415 339 5300", "website": "https://www.nektar.com", "industry": "", "sector": "", "longBusinessSummary": "Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. The company is developing rezpegaldesleukin, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; and NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer squamous cell carcinoma and colorectal cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc.  The company was incorporated in 1990 and is headquartered in San Francisco, California.", "fullTimeEmployees": 216, "companyOfficers": [{"maxAge": 1, "name": "Mr. Howard W. Robin", "age": 69, "title": "CEO, Pres & Director", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": {"raw": 1834165, "fmt": "1.83M", "longFmt": "1,834,165"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark A. Wilson", "age": 50, "title": "Sr. VP, Chief Legal Officer & Sec.", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 749993, "fmt": "749.99k", "longFmt": "749,993"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jonathan  Zalevsky Ph.D.", "age": 47, "title": "Sr. VP & Chief R&D Officer", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 1246371, "fmt": "1.25M", "longFmt": "1,246,371"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sandra A. Gardiner", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Vivian  Wu", "title": "Director of Investor Relations & Corp. Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert  Bacci", "title": "Sr. VP of HR & Facilities Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jennifer  Ruddock", "title": "Chief Bus. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mary  Tagliaferri L.Ac., M.D.", "age": 56, "title": "Chief Medical Officer", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Loui  T. Madakamutil", "title": "VP and Head of Discovery & Research", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 2, "overallRisk": 5, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}